European Commission logo
italiano italiano
CORDIS - Risultati della ricerca dell’UE
CORDIS

Consolidating the capacities of EATRIS-ERIC for Personalised Medicine

Descrizione del progetto

Superare le difficoltà della medicina personalizzata

L’infrastruttura europea di ricerca traslazionale avanzata in medicina (EATRIS) fornisce un accesso integrato all’esperienza combinata e alle tecnologie di alto livello per lo sviluppo di nuovi prodotti nella medicina traslazionale. Nei primi cinque anni, essa ha fornito i propri servizi a una vasta gamma di utenti quali il mondo accademico, le PMI, i grandi istituti di ricerca farmaceutica e biotecnologica. Il progetto EATRIS-Plus, finanziato dall’UE, intende sostenere la sostenibilità a lungo termine dell’EATRIS offrendo alla comunità accademica strumenti scientifici avanzati, migliorando il proprio modello finanziario e rafforzando la propria leadership nel campo della medicina personalizzata. Il progetto si svolgerà in 16 paesi dell’Unione Europea, sostenendo la raccolta e l’utilizzo delle capacità accademiche traslazionali nelle tecnologie omiche per intensificare la ricerca relativa alle sfide scientifiche e sociali legate alla medicina personalizzata.

Obiettivo

In the first five years of operations, EATRIS has shown strong proof of concept of the value of the services portfolio, with users ranging from academia, SMEs, large pharma, to biotech and research funding organisations. The overarching aim of EATRIS-Plus is to support the long-term sustainability (LTS) of EATRIS by delivering innovative scientific tools to the research community, strengthening the infrastructure’s financial model and reinforcing EATRIS leadership in the European Research Area (ERA), particularly in the field of Personalised Medicine (PM) research and development.
Specific objectives are: (i) To consolidate EATRIS capacities in the field of PM to better serve academia and industry and augment the number of EATRIS Innovation Hubs with large pharma; (ii) To further strengthen the LTS of EATRIS financial model; (iii) To drive patient empowerment through active involvement in the infrastructure’s operations; (iv) To expand strategic partnerships with Research Infrastructures and other relevant stakeholders. The proposal relies on a scientific and technological programme combined with capacity-building activities across 16 EU countries, with the support of two umbrella organisations representing patient organisations and SMEs.
EATRIS-Plus will help pooling and exploiting the translational academic capacities of the infrastructure in omic technologies to enable researchers to better address the scientific and societal challenge of PM. Additionally, the coordination office and 13 existing national nodes of the infrastructure will participate in implementing joint outreach, training, industry engagement and international collaboration activities to further build national capacity, increase users’ trust and strengthen EATRIS and the ERA global scientific leadership.

Invito a presentare proposte

H2020-INFRADEV-2018-2020

Vedi altri progetti per questo bando

Bando secondario

H2020-INFRADEV-2019-2

Meccanismo di finanziamento

RIA - Research and Innovation action

Coordinatore

EATRIS ERIC
Contribution nette de l'UE
€ 848 887,50
Indirizzo
DE BOELELAAN 1118
1081 HZ Amsterdam
Paesi Bassi

Mostra sulla mappa

Regione
West-Nederland Noord-Holland Groot-Amsterdam
Tipo di attività
Research Organisations
Collegamenti
Costo totale
€ 972 507,50

Partecipanti (25)